GE Healthcare seeks permission for self manufacturing of Optison
If approved, GE will manufacture Optison at its Oslo facility thereby becoming the only contrast media manufacturer to supply its own stock to the US market. GE Healthcare
Insilico Medicine has entered into a strategic collaboration agreement with Takeda to deploy its AI-based Pharma.AI platform in the discovery and development of drug candidates.